EBITDA
Lincoln Pharmaceuticals Ltd Reports 26.66% Rise in Profit Rs. 19.01 Crore
RIL Posted Record Quarterly Consolidated EBITDA At ₹ 40179 Cr with 45.8% YoY Growth
Adani Transmission Posted Robust year registering 50% growth in EBITDA and 26% growth in PAT
/smstreet/media/agency_attachments/3LWGA69AjH55EG7xRGSA.png)
/smstreet/media/media_files/mVuTGGnJRG7hxsV5UYTr.jpg)
/smstreet/media/media_files/gCMu3LaYx6k7Ky3YSJ41.jpg)
/smstreet/media/media_files/pxP7WfvQ5l9No8MB3oE6.jpg)
/smstreet/media/post_banners/udBKuiDSy7fnif1rT61c.jpg)
/smstreet/media/post_banners/mq4iO3r9bh5FWb2aC9UJ.jpg)
/smstreet/media/post_banners/5czc2zNGwXB8TVKKjKMq.jpg)
/smstreet/media/post_banners/3yDKNmj1SQ0eXASWe7WU.png)
/smstreet/media/post_banners/gfqRSbiu4cvobvV6ApRe.jpeg)
/smstreet/media/post_banners/8Cm32EpltRYLgSEafBvh.jpg)
/smstreet/media/post_banners/ilCRlaN2mqOhq3uh5K9J.jpg)
